MarketInOut Stock Screener Log In | Sign Up

Galderma Group AG

SIX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/29/2026 17:30
Galderma Group AG stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSIX
Market Capitalization44,213 mln
Float185 mln
Earnings Date03/11/2027

EPS

2.90
Stretched

P / E

65.31
Richly valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.68
Likely reliable

1-Year Forecast

203.71
Modest upside

Relative Strength

98 / 100
Top performer

Business Description

Galderma is a Swiss company focused entirely on skin health, with products spanning cosmetic treatments, everyday skincare, and prescription medicines for skin conditions. Founded in 1981 and based in Zug, Switzerland, the company serves patients, consumers, and medical professionals across the globe. Its well-known brands address a wide range of needs, from anti-aging injectables and skin hydration to acne, rosacea, and other common skin concerns.

Key Fundamentals

EPS2.90
P/E65.31
ROE10.67
RPS20.70
ROIC8.49
ROA6.46
Interest Cover8.54
EBITDA, mln1,106
EV / EBITDA41.86
EV / EBIT54.79
Revenue, mln4,673
EV / Revenue9.91

Quote Details

Last 189.70
Change 4.5 (2.43%)
Open 186.30
Volume 473,705
Turnover 89,861,840
Average Volume 554,437

Financial Ratios

Pre-Tax Profit Margin16
Leverage Ratio1.65
Current Ratio1.24
Price / Book6.51
Price / Cash Flow46.37
Price / Free Cash Flow52.84
Debt / Equity0.33
Price / Sales9.33
PEG Ratio1.27

Financial Strength

Altman Z-Score7.74
Piotroski F-Score 7 / 9
Beneish M-Score-2.68
1-Year Target Price203.71

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.61% 70 / 100   
1 Month 14.38% 98 / 100   
2 Months 9.27% 83 / 100   
6 Months 15.57% 82 / 100   
1 Year 36.08% 87 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog